Equity Capital Markets

Company · CIK 1829802

Faeth Therapeutics, Inc.

Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26

CIK1829802 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressTX
ListedFTH (Nasdaq)
First annual or quarterly report2021-03-30

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-296894
ShelfEffective
 2026-06-182026-06-181
333-295362
ShelfEffective
 2026-04-282026-06-122
333-263567
ShelfEffective
 2022-03-152023-08-174
333-252138
IPOFinal prospectus
 2021-01-152021-02-044

Filings

12
FiledFilingRegistrationAccession
2026-06-18S-3ASRShelf registered 333-2968940001193125-26-275791
2026-06-12EFFECTDeclared effective 333-2953629999999995-26-001978
2026-04-28S-3Shelf registered 333-2953620001193125-26-183535
2023-08-17424B5Shelf takedown 333-2635670001193125-23-215140
2022-05-09EFFECTDeclared effective 333-2635679999999995-22-001367
2022-05-09424B5Shelf takedown 333-2635670001193125-22-145041
2022-03-15S-3Shelf registered 333-2635670001193125-22-076072
2021-02-04424B4Final prospectus 333-2521380001193125-21-028832
2021-02-03EFFECTDeclared effective 333-2521389999999995-21-000416
2021-02-01S-1/AAmendment 333-2521380001193125-21-023615
2021-01-15S-1Registration filed 333-2521380001193125-21-010054
2020-11-12DRSDraft made public 377-037750000950123-20-011480

All filings of this company · CSV